Search Results - "YASUDA NOBUYUKI" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

$Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes$

Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes

by Kuboi, Yoshikazu, Nishimura, Miyuki, Ikeda, Wataru, Nakatani, Tomoya, Seki, Yukie, Yamaura, Yui, Ogawa, Kana, Hamaguchi, Akiko, Muramoto, Kenzo, Mizuno, Keiko, Ogasawara, Hideaki, Yamauchi, Toshihiko, Yasuda, Nobuyuki, Onodera, Hiroshi, Imai, Toshio
Published in International immunology (26.04.2019)

Get full text

Journal Article

Role of Anti‐Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental Arthritis

Role of Anti‐Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental Arthritis

by Hoshino‐Negishi, Kana, Ohkuro, Masayoshi, Nakatani, Tomoya, Kuboi, Yoshikazu, Nishimura, Miyuki, Ida, Yoko, Kakuta, Jungo, Hamaguchi, Akiko, Kumai, Minoru, Kamisako, Tsutomu, Sugiyama, Fumihiro, Ikeda, Wataru, Ishii, Naoto, Yasuda, Nobuyuki, Imai, Toshio
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.02.2019)

Get full text

Journal Article

$Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway$

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway

by Imai, Toshio, Yasuda, Nobuyuki
Published in Inflammation and Regeneration (01.01.2016)

Get full text

Journal Article Book Review

$Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study$

Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study

by Tabuchi, Hiroko, Katsurabara, Toshinori, Mori, Masahiko, Aoyama, Muneo, Obara, Takashi, Yasuda, Nobuyuki, Kawano, Tetsu, Imai, Toshio, Ieiri, Ichiro, Kumagai, Yuji
Published in Journal of clinical pharmacology (01.05.2019)

Get more information

Journal Article

$Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis$

Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis

by Tanaka, Yoshiya, Takeuchi, Tsutomu, Umehara, Hisanori, Nanki, Toshihiro, Yasuda, Nobuyuki, Tago, Fumitoshi, Kawakubo, Makoto, Kitahara, Yasumi, Hojo, Seiichiro, Kawano, Tetsu, Imai, Toshio
Published in Modern rheumatology (02.01.2018)

Get full text

Journal Article

A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs

A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs

by Tanaka, Yoshiya, Takeuchi, Tsutomu, Yamanaka, Hisashi, Nanki, Toshihiro, Umehara, Hisanori, Yasuda, Nobuyuki, Tago, Fumitoshi, Kitahara, Yasumi, Kawakubo, Makoto, Torii, Kentaro, Hojo, Seiichiro, Kawano, Tetsu, Imai, Toshio
Published in Modern rheumatology (04.07.2021)

Get full text

Journal Article

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival

by Kuboi, Yoshikazu, Kuroda, Yukiko, Ohkuro, Masayoshi, Motoi, Sotaro, Tomimori, Yoshiya, Yasuda, Hisataka, Yasuda, Nobuyuki, Imai, Toshio, Matsuo, Koichi
Published in JBMR plus (01.10.2022)

Get full text

Journal Article

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

by Tanaka, Yoshiya, Hoshino-Negishi, Kana, Kuboi, Yoshikazu, Tago, Fumitoshi, Yasuda, Nobuyuki, Imai, Toshio
Published in ImmunoTargets and therapy (01.01.2020)

Get full text

Journal Article

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

by Yasuda, Nobuyuki, Inoue, Takashi, Nagakura, Tadashi, Yamazaki, Kazuto, Kira, Kazunobu, Saeki, Takao, Tanaka, Isao
Published in Biochemical and biophysical research communications (15.11.2002)

Get full text

Journal Article

Comparison of Medically Versus Surgically Treated Acute Type A Aortic Dissection in Patients <80 Years Old Versus Patients ≥80 Years Old

Comparison of Medically Versus Surgically Treated Acute Type A Aortic Dissection in Patients <80 Years Old Versus Patients ≥80 Years Old

by Yanagisawa, Satoshi, MD, Yuasa, Takeshi, MD, Suzuki, Noriyuki, MD, Hirai, Toshihisa, MD, Yasuda, Nobuyuki, MD, Miki, Ken, MD, Yasuura, Kenzo, MD, Horiuchi, Kazutaka, MD, Tanaka, Toshikazu, MD
Published in The American journal of cardiology (01.08.2011)

Get full text

Journal Article

Does N-Acetylcysteine Reduce the Incidence of Contrast-Induced Nephropathy and Clinical Events in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction?

Does N-Acetylcysteine Reduce the Incidence of Contrast-Induced Nephropathy and Clinical Events in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction?

by Tanaka, Akihito, Suzuki, Yoriyasu, Suzuki, Noriyuki, Hirai, Toshihisa, Yasuda, Nobuyuki, Miki, Ken, Fujita, Masaya, Tanaka, Toshikazu
Published in Internal Medicine (01.01.2011)

Get full text

Journal Article

Metformin Causes Reduction of Food Intake and Body Weight Gain and Improvement of Glucose Intolerance in Combination with Dipeptidyl Peptidase IV Inhibitor in Zucker fa/fa Rats

Metformin Causes Reduction of Food Intake and Body Weight Gain and Improvement of Glucose Intolerance in Combination with Dipeptidyl Peptidase IV Inhibitor in Zucker fa/fa Rats

by Yasuda, Nobuyuki, Inoue, Takashi, Nagakura, Tadashi, Yamazaki, Kazuto, Kira, Kazunobu, Saeki, Takao, Tanaka, Isao
Published in The Journal of pharmacology and experimental therapeutics (01.08.2004)

Get full text

Journal Article

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

Comparison of Efficacies of a Dipeptidyl Peptidase IV Inhibitor and α-Glucosidase Inhibitors in Oral Carbohydrate and Meal Tolerance Tests and the Effects of Their Combination in Mice

by Yamazaki, Kazuto, Inoue, Takashi, Yasuda, Nobuyuki, Sato, Yoshiaki, Nagakura, Tadashi, Takenaka, Osamu, Clark, Richard, Saeki, Takao, Tanaka, Isao
Published in Journal of Pharmacological Sciences (2007)

Get full text

Journal Article

Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats

Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats

by Nagakura, Tadashi, Yasuda, Nobuyuki, Yamazaki, Kazuto, Ikuta, Hironori, Yoshikawa, Seiji, Asano, Osamu, Tanaka, Isao
Published in Biochemical and biophysical research communications (08.06.2001)

Get full text

Journal Article

7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one Is a Novel Competitive and Selective Inhibitor of Dipeptidyl Peptidase IV with an Antihyperglycemic Activity

7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one Is a Novel Competitive and Selective Inhibitor of Dipeptidyl Peptidase IV with an Antihyperglycemic Activity

by Yamazaki, Kazuto, Yasuda, Nobuyuki, Inoue, Takashi, Nagakura, Tadashi, Kira, Kazunobu, Shinoda, Masanobu, Saeki, Takao, Tanaka, Isao
Published in The Journal of pharmacology and experimental therapeutics (01.12.2006)

Get full text

Journal Article

Effects of the Combination of a Dipeptidyl Peptidase IV Inhibitor and an Insulin Secretagogue on Glucose and Insulin Levels in Mice and Rats

Effects of the Combination of a Dipeptidyl Peptidase IV Inhibitor and an Insulin Secretagogue on Glucose and Insulin Levels in Mice and Rats

by Yamazaki, Kazuto, Yasuda, Nobuyuki, Inoue, Takashi, Yamamoto, Eiichi, Sugaya, Yukiko, Nagakura, Tadashi, Shinoda, Masanobu, Clark, Richard, Saeki, Takao, Tanaka, Isao
Published in The Journal of pharmacology and experimental therapeutics (01.02.2007)

Get full text

Journal Article

Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition

Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition

by Nagakura, Tadashi, Yasuda, Nobuyuki, Yamazaki, Kazuto, Ikuta, Hironori, Tanaka, Isao
Published in Metabolism, clinical and experimental (01.01.2003)

Get full text

Journal Article

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes

by Hiyoshi, Hironobu, Yanagimachi, Mamoru, Ito, Masashi, Yasuda, Nobuyuki, Okada, Toshimi, Ikuta, Hironori, Shinmyo, Daisuke, Tanaka, Keigo, Kurusu, Nobuyuki, Yoshida, Ichiro, Abe, Shinya, Saeki, Takao, Tanaka, Hiroshi
Published in Journal of lipid research (01.01.2003)

Get full text

Journal Article

The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight

The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight

by Yamazaki, Kazuto, Yasuda, Nobuyuki, Inoue, Takashi, Nagakura, Tadashi, Kira, Kazunobu, Saeki, Takao, Tanaka, Isao
Published in European journal of pharmacology (19.03.2004)

Get full text

Journal Article

Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study

Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study

by Tanaka, Yoshiya, Takeuchi, Tsutomu, Yamanaka, Hisashi, Nanki, Toshihiro, Umehara, Hisanori, Yasuda, Nobuyuki, Tago, Fumitoshi, Kitahara, Yasumi, Kawakubo, Makoto, Torii, Kentaro, Hojo, Seiichiro, Kawano, Tetsu, Imai, Toshio
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.04.2021)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[20]